The Real Reason Cybin Bought Entheon’s DMT Clinical Trial
In a rare move Cybin aquires a phase 1 DMT clinical trial from Entheon Biomedical. CEO Doug Drysdale explains why in a Reddit AMA
clinical trial
Canada Halts MDMA Clinical Trial Over Concerns for Participant Safety
Deficiancies in good clinical practices and accurate record keeping stops an MDMA clinical trial in its tracks
End of content
End of content